Imaging of pancreatic tumours in mice using radiolabelled anti-Claudin4 antibodies

Imaging of pancreatic tumours in mice using radiolabelled anti-Claudin4 antibodies

Bibliographic Details
Main Authors:	Mosley, M, Knight, J, Koustoulidou, S, Cornelissen, B
Format:	Conference item
Published:	Springer Verlag 2016

Similar Items

Imaging of claudin-4 in pancreatic ductal adenocarcinoma using a radiolabelled anti-claudin-4 monoclonal antibody
by: Torres, J, et al.
Published: (2017)

Radiolabeled cCPE peptides for SPECT imaging of claudin-4 overexpression in pancreatic cancer
by: Baguna-Torres, J, et al.
Published: (2020)

Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours
by: Knight, J, et al.
Published: (2019)

Dual-isotope imaging reveals inter-individual differences in passive uptake of radiolabelled antibodies in tumours
by: Knight, J, et al.
Published: (2018)

Radiolabeled Anti-Claudin 4 and Anti-Prostate Stem Cell Antigen: Initial Imaging in Experimental Models of Pancreatic Cancer
by: Catherine A. Foss, et al.
Published: (2007-03-01)

Microscale radiolabelling of antibodies with zirconium-89 for positron emission tomography
by: Knight, J, et al.
Published: (2015)

Claudin-4 SPECT imaging allows detection of aplastic lesions in a mouse model of breast cancer
by: Mosley, M, et al.
Published: (2015)

Scaling-down antibody radiolabeling reactions with zirconium-89
by: Knight, JC, et al.
Published: (2016)

Imaging p53 in Pancreatic Ductal Adenocarcinoma (PDAC)
by: Koustoulidou, S, et al.
Published: (2016)

Radiolabelled Bacillus anthracis toxin-based probes for molecular imaging of MMP activity in tumour models
by: Xavier, M, et al.
Published: (2018)

[18F]Olaparib: Precision radiolabelling of PARP inhibitors for in vivo imaging
by: Wilson, T, et al.
Published: (2018)

Radiolabeled Antibodies for Cancer Imaging and Therapy
by: Sagun Parakh, et al.
Published: (2022-03-01)

Imaging the DNA damage response with PET and SPECT
by: Knight, J, et al.
Published: (2017)

Claudin and pancreatic cancer
by: Chen Wang, et al.
Published: (2023-03-01)

Biodistribution of a Radiolabeled Antibody in Mice as an Approach to Evaluating Antibody Pharmacokinetics
by: Kevin J. H. Allen, et al.
Published: (2018-12-01)

Tumor imaging using radiolabelled matrix metalloproteinase-activated anthrax proteins
by: Xavier, M, et al.
Published: (2019)

Immuno-imaging of ICAM-1 in tumours by SPECT
by: Mosley, M, et al.
Published: (2020)

Imaging p53 in pancreatic ductal adenocarcinoma
by: Koustoulidou, S
Published: (2017)

Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
by: Kaltsas, G, et al.
Published: (2005)

In vivo tumour imaging employing regional delivery of novel gallium radiolabelled polymer composites
by: Ross W. Stephens, et al.
Published: (2021-03-01)

Antibody-mediated targeting of Claudins in cancer
by: Benjamin Vonniessen, et al.
Published: (2024-02-01)

89Zr-anti-γH2AX-TAT allows early monitoring of response to gemcitabine and capecitabine therapy in pancreatic ductal adenocarcinoma
by: Knight, J, et al.
Published: (2016)

Current Status of Radiolabeled Monoclonal Antibodies Targeting PSMA for Imaging and Therapy
by: Mohammed Abusalem, et al.
Published: (2023-09-01)

The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours.
by: Kaltsas, G, et al.
Published: (2001)

Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibody
by: Hayat Bähr-Mahmud, et al.
Published: (2023-12-01)

Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors.
by: Denis R Beckford Vera, et al.
Published: (2018-01-01)

Radiolabelled Bacillus anthracis toxin-based probes for molecular imaging of MMP activity in tumour models
by: Xavier, M
Published: (2018)

Improved Characteristics of RANKL Immuno-PET Imaging Using Radiolabeled Antibody Fab Fragments
by: Jonatan Dewulf, et al.
Published: (2022-04-01)

Imaging neuroendocrine tumours with radiolabelled somatostatin analogues and X-ray computed tomography: a comparative study.
by: King, C, et al.
Published: (1993)

Antibody-Based Approaches to Target Pancreatic Tumours
by: Marie Sorbara, et al.
Published: (2022-07-01)

Liposomes targeting the cancer cell-exposed receptor, claudin-4, for pancreatic cancer chemotherapy
by: Chaeeun Bang, et al.
Published: (2023-05-01)

Claudin 4 in pancreatic β cells is involved in regulating the functional state of adult islets
by: Hongtu Li, et al.
Published: (2020-01-01)

Radiolabeled Anti-Adenosine Triphosphate Synthase Monoclonal Antibody as a Theragnostic Agent Targeting Angiogenesis
by: Bok-Nam Park PhD, et al.
Published: (2017-12-01)

Early detection of pancreatic cancer in KPC mice by imaging DNA damage signalling
by: Knight, J, et al.
Published: (2018)

Radiolabelled copper complexes for cancer imaging
by: Hueting, R
Published: (2011)

Imaging Bacteria with Radiolabelled Probes: Is It Feasible?
by: Alberto Signore, et al.
Published: (2020-07-01)

Radiolabeled Liposomes for Nuclear Imaging Probes
by: Ho Ying Low, et al.
Published: (2023-04-01)

Radiolabeling Strategies of Nanobodies for Imaging Applications
by: Jim Küppers, et al.
Published: (2021-08-01)

Evaluating the Targeting of a <i>Staphylococcus-aureus</i>-Infected Implant with a Radiolabeled Antibody In Vivo
by: Bruce van Dijk, et al.
Published: (2023-02-01)

Radionuclide treatment of neuroendocrine tumours with the novel radiolabelled analogue Y-90-SMT 487
by: Carroll, P, et al.
Published: (2003)